Fitch Ratings assigns ACBA-CREDIT AGRICOLE BANK long-term issuer default rating at “B +” with stable outlook

YEREVAN, June 23. /ARKA/. The international Fitch Ratings has assigned the ACBA-CREDIT AGRICOLE BANK a long-term Issuer Default Rating (IDR) at “B +” with a stable outlook, the bank’s press service reported today. The Yerevan-based bank attributed the assessment to its internal financial viability.

The Fitch Ratings based its assessment on ACBA-CREDIT AGRICOLE BANK’s absolute leading position in financing Armenia’s agricultural sector, the saturation of the infrastructure, including the presence of branches in all regions of the country, as well as a high level of liquidity.

Fitch notes also that in recent years, in the face of a difficult macroeconomic situation, the bank has focused on improving the quality of assets, as a result of which it limited the rapid growth of its loan portfolio.

All this, in turn, helped and later stimulated a decrease in the riskiness of assets and growth in profitability. The Fitch’s assessment is the highest for companies in Armenia. It confirms the transparent financial structure of the bank and its leading position.

ACBA was established in 1996 as part of EU’s TACIS program. As a result of a long-term and mutually beneficial cooperation between ACBA Bank and the French Credit Agricole the latter became the biggest shareholder of ACBA in 2006, September. ACBA was restructured, becoming a closed joint stock company and was renamed ACBA CREDIT AGRICOLE BANK. –0–

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

LATEST NEWS

spot_imgspot_imgspot_img